Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Covid crawled time : 13:01 save search
Rigel Announces Completion of Patient Enrollment for NIH/NHLBI-Sponsored Phase 2 Trial of Fostamatinib in Hospitalized COVID-19 Patients
Published: 2021-03-11 (Crawled : 13:01) - biospace.com/
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: 0.52%
H: 0.36%
C: -0.63%
RIGL | $1.07 1.91% 1.87% 810K
|
Health Technology
|
| O: 1.28%
H: 6.55%
C: 6.55%
covid phase 2 trial enroll
Quantum Leap Healthcare Collaborative Discontinues Testing of Aerpio Pharmaceutical’s Razuprotafib in I-SPY COVID Trial
Published: 2021-03-05 (Crawled : 13:01) - globenewswire.com
GOSS 4 | $0.7837 -2.77% -2.85% 670K
|
Health Technology
|
| O: 0.31%
H: 0.52%
C: -1.14%
covid test trial collaboration
Adaptive Biotechnologies Launches T-Detect™ COVID, First Clinical T-Cell Based Test for Patients to Confirm Recent or Prior COVID-19 Infection
Published: 2021-02-23 (Crawled : 13:01) - globenewswire.com
ADPT | $2.41 3.21% 3.11% 2.3M
|
Commercial Services
|
| O: -1.27%
H: 2.57%
C: 1.36%
covid test biotech iot t-cell injection infections
Pfizer and BioNTech Publish Results of Study Showing COVID-19 Vaccine Elicits Antibodies that Neutralize Pseudovirus Bearing the SARS-CoV-2 U.K. Strain Spike Protein in Cell Culture
Published: 2021-01-20 (Crawled : 13:01) - globenewswire.com
PFE A | $26.0 2.4% -0.15% 38M
|
Health Technology
|
| O: 0.16%
H: 0.05%
C: -0.79%
BNTX | $86.82 0.75% 0.75% 1.6M
|
Health Technology
|
| O: -0.28%
H: 1.04%
C: -1.13%
covid results vaccine antibody sars-cov-2
CorVel and 1health Partner to Provide At-Home COVID-19 Testing for Essential Workers and Companies
Published: 2021-01-12 (Crawled : 13:01) - globenewswire.com
CRVL 4 | $235.28 2.47% 2.41% 31K
|
Finance
|
| O: -0.14%
H: 2.09%
C: 1.94%
covid test covid-19
Fulgent Genetics Extends Partnership with New York City Test and Trace for COVID-19 Testing, Awarded Contract for 2021 School Year
Published: 2020-12-29 (Crawled : 13:01) - globenewswire.com
FLGT | $20.34 1.14% 1.13% 160K
|
Health Services
|
| O: 4.53%
H: 6.38%
C: 3.94%
covid test partnership contract trace
Kiniksa Announces Data from U.S. Investigator-Initiated Study of Mavrilimumab in Severe COVID-19 Pneumonia and Hyperinflammation
Published: 2020-12-22 (Crawled : 13:01) - globenewswire.com
KNSA | $16.93 0.3% 0.3% 380K
|
Health Technology
|
| O: -0.25%
H: 2.4%
C: 0.05%
covid
CFOs Taking More Prominent Strategic and Enterprise-Building Responsibilities Following Their Critical COVID-19 Work, New Survey Shows
Published: 2020-12-14 (Crawled : 13:01) - globenewswire.com
FCN | $211.25 1.74% 0.0% 330K
|
Commercial Services
|
| O: 0.07%
H: 0.74%
C: -0.32%
covid response
Enlivex Reports Positive Interim Results From Phase II Clinical Trial Evaluating Allocetra in Severe and Critical COVID-19 Patients
Published: 2020-12-03 (Crawled : 13:01) - globenewswire.com
ENLV | $1.4 -4.23% 110K
|
Health Technology
|
| O: 28.9%
H: 29.17%
C: 6.94%
covid positive results trial
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.